Publications

This page collects the scientific contributions of the Principal Investigator throughout his academic career, including research conducted during doctoral and postdoctoral training; and research performed by the laboratory since its establishment in January 2025. Lab members are indicated in bold. The complete list is available on PubMed.

2026

  1. Immunocompetent preclinical mouse models of brain cancer

    Álvarez-Prado, ÁF.

    Methods in Molecular Biology 2026; 2959:165-177

2025

  1. Cancer cell and microenvironmental rewiring by ADAR1 loss impairs glioblastoma tumor growth and extends survival

    Álvarez-Prado ÁF*, Hernández-Barranco A, Rentsch L, Costa CF, Joyce JA*.

    Cell Reports 2025; 44(9):116151

    * Co-corresponding authors.

  2. Tumor-Infiltrating Clonal Hematopoiesis

    Pich O, Bernard E, Zagorulya M, Rowan A, (...), Álvarez-Prado ÁF, (...) Swanton C.

    The New England Journal of Medicine 2025; 392(16):1594-1608

2023

  1. The local microenvironment drives activation of neutrophils in human brain tumors

    Maas RR, Soukup K, Fournier N, (...), Álvarez-Prado ÁF, (...), Joyce JA.

    Cell 2023; 186(21):4546-4566.e27

  2. Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors

    Álvarez-Prado ÁF, Maas RR, Soukup K, Klemm F, Kornete M, (...), Joyce JA.

    Cell Reports Medicine 2023; 4(1):100900

2021

  1. An integrated pipeline for comprehensive analysis of immune cells in human brain tumor clinical samples

    Maas RR, Soukup K, Klemm F, (...), Álvarez-Prado ÁF, (...), Joyce JA.

    Nature Protocols 2021; 16(10):4692-4721

  2. Activation-induced deaminase is critical for the establishment of DNA methylation patterns prior to the germinal center reaction

    Català-Moll F, Ferreté-Bonastre AG, Li T, (...), Álvarez-Prado ÁF, (...), Ballestar E.

    Nucleic Acids Research 2021; 49(9):5057-5073

2020

  1. Interplay between UNG and AID governs intratumoral heterogeneity in mature B cell lymphoma

    Delgado P, Álvarez-Prado ÁF, Marina-Zárate E, (...), Ramiro AR.

    PLOS Genetics 2020; 16(12):e1008960

  2. Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL

    Baliñas-Gavira C, Rodríguez MI, Andrades A, (...), Álvarez-Prado ÁF, (...), Medina PP.

    Leukemia 2020; 34(10):2722-2735

2019

  1. Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID

    Rodríguez-Hernández G, Opitz FV, Delgado P, Walter C, Álvarez-Prado ÁF, (...), Sanchez-Garcia I & Borkhardt A.

    Nature Communications 2019; 10(1):5563

2018

  1. A broad atlas of somatic hypermutation allows prediction of activation-induced deaminase targets

    Álvarez-Prado ÁF, Pérez-Durán P, Pérez-García A, Benguria A, Torroja C, de Yébenes VG, Ramiro AR.

    Journal of Experimental Medicine 2018; 215(3):761-771

2017

  1. CTCF orchestrates the germinal centre transcriptional program and prevents premature plasma cell differentiation

    Pérez-García A, Marina-Zárate E, Álvarez-Prado ÁF, Ligos JM, Galjart N, Ramiro AR.

    Nature Communications 2017; 8:16067

  2. miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma

    Bartolomé-Izquierdo N, de Yébenes VG, Álvarez-Prado ÁF, Mur SM, Lopez Del Olmo JA, Roa S, Vázquez J, Ramiro AR.

    Blood 2017; 129(17):2408-2419

  3. Primary T-cell immunodeficiency with functional revertant somatic mosaicism in CD247

    Marin AV, Jiménez-Reinoso A, Briones AC, (...), Álvarez-Prado ÁF, (...), Regueiro JR & Garcillán B.

    Journal of Allergy and Clinical Immunology 2017; 139(1):347-349.e8

2012

  1. Self-assembled protein arrays from an Ornithodoros moubata salivary gland expression library

    Manzano-Román R, Díaz-Martín V, González-González M, Matarraz S, Álvarez-Prado ÁF, (...), Fuentes M.

    Journal of Proteome Research 2012; 1(12):5972-82